FY2025 EPS Forecast for Encompass Health Boosted by Analyst

Encompass Health Corporation (NYSE:EHC) – Stock analysts at William Blair boosted their FY2025 earnings estimates for shares of Encompass Health in a report released on Friday, October 31st. William Blair analyst J. Haase now forecasts that the company will post earnings of $5.29 per share for the year, up from their previous forecast of $5.24. The consensus estimate for Encompass Health’s current full-year earnings is $4.80 per share. William Blair also issued estimates for Encompass Health’s Q1 2026 earnings at $1.51 EPS, Q2 2026 earnings at $1.44 EPS, Q3 2026 earnings at $1.42 EPS and Q4 2026 earnings at $1.35 EPS.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The company had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS.

A number of other research analysts have also commented on the stock. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. UBS Group upped their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Zacks Research upgraded shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Bank of America lifted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Finally, Truist Financial lifted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. Three investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Stock Up 0.9%

Encompass Health stock opened at $117.17 on Monday. The firm has a market capitalization of $11.80 billion, a PE ratio of 22.15, a P/E/G ratio of 2.20 and a beta of 0.93. The company’s 50-day moving average is $124.00 and its 200-day moving average is $119.29. Encompass Health has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Hedge Funds Weigh In On Encompass Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Citizens National Bank Trust Department acquired a new stake in Encompass Health in the third quarter worth $26,000. WPG Advisers LLC acquired a new position in shares of Encompass Health during the first quarter valued at about $27,000. First Horizon Corp acquired a new position in shares of Encompass Health during the third quarter valued at about $34,000. Westside Investment Management Inc. grew its holdings in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after buying an additional 101 shares during the last quarter. Finally, Root Financial Partners LLC acquired a new position in shares of Encompass Health during the third quarter valued at about $39,000. Institutional investors own 97.25% of the company’s stock.

Insider Activity

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio is presently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.